Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Phase 1/1b Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Terminated
Toxicity -Two DLT events occurred
Other terminated trials from H. Lee Moffitt Cancer Center and Research Institute
- Glioma of Brain · Phase EARLY_PHASE1 · May 2023
- Chronic Lymphocytic Leukemia · Phase PHASE2 · May 2023
- Chronic Lymphocytic Leukemia · Phase PHASE2 · Oct 2022
- Hepatocellular Carcinoma · Phase PHASE1 · Oct 2022
- Cutaneous Squamous Cell Carcinoma · Phase PHASE2 · May 2022
See all terminations from H. Lee Moffitt Cancer Center and Research Institute
Listed as NCT03760523, this PHASE1 trial focuses on Acute Myeloid Leukemia and remains terminated or withdrawn. Sponsored by H. Lee Moffitt Cancer Center and Research Institute, it has been updated 26 times since 2019, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
26 versions recorded-
Feb 2026 — Present [monthly]
Terminated PHASE1
-
Oct 2025 — Feb 2026 [monthly]
Terminated PHASE1
-
Jul 2025 — Oct 2025 [monthly]
Terminated PHASE1
-
Apr 2025 — Jul 2025 [monthly]
Terminated PHASE1
-
Jan 2025 — Apr 2025 [monthly]
Terminated PHASE1
▶ Show 21 earlier versions
-
Sep 2024 — Jan 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Mar 2024 — Jul 2024 [monthly]
Terminated PHASE1
-
Nov 2023 — Mar 2024 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Oct 2023 — Nov 2023 [monthly]
Recruiting PHASE1
-
Aug 2023 — Oct 2023 [monthly]
Recruiting PHASE1
-
May 2023 — Aug 2023 [monthly]
Recruiting PHASE1
-
Dec 2022 — May 2023 [monthly]
Recruiting PHASE1
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE1
-
Jun 2022 — Nov 2022 [monthly]
Recruiting PHASE1
-
Jan 2022 — Jun 2022 [monthly]
Recruiting PHASE1
-
Sep 2021 — Jan 2022 [monthly]
Recruiting PHASE1
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Aug 2020 — Oct 2020 [monthly]
Recruiting PHASE1
-
Mar 2020 — Aug 2020 [monthly]
Recruiting PHASE1
-
Oct 2019 — Mar 2020 [monthly]
Recruiting PHASE1
-
May 2019 — Oct 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE1
-
Dec 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- H. Lee Moffitt Cancer Center and Research Institute
- Minneamrita Therapeutics LLC
For direct contact, visit the study record on ClinicalTrials.gov .